The first recombinant bacterium to be examined in clinical trials was Lactobacillus lactis encoding the gene for the immunosuppressive cytokine interleukin-10 (IL-10) in 2006 (LL-Thy12).89 The study's aim was determining whether the bacteria could reduce inflammation from Crohn's disease. This evidence concerns the gene IL10 and Crohn disease.